http://smallcapvoice.com/blog/wp-content/uploads/spph-10-22-10.mp3

Dr. Max Arella, President of Spencer Pharmaceutical Inc. (Pink Sheets: SPPH) joined us at SmallCapVoice.com to explain how Spencer Pharmaceutical Inc. is a US-based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.

The Company recently announced that it has applied for a Level 1 certificate with the International Council for Corporate Governance (ICCG). The certificate application is a 2 step process.